Table 4.
Association of Adiposity Measures with Type 2 Diabetes in African-Caribbean Men (N = 718, Total Sample)
| Adjustment model | BMI, SD = 4.7 kg/m2 | VAT, SD = 57 cm3 | PAT, SD = 23 cm3 | Liver attenuation*, SD = 8.1 HU | Muscle attenuation*, SD = 4.2 mg/cm3 |
|---|---|---|---|---|---|
| Model 1 (age adjusted) | 1.62 (1.36–1.92) | 1.77 (1.47–2.13) | 1.66 (1.38–1.99) | 1.70 (1.44–2.01) | 1.42 (1.20–1.69) |
| Model 2 (age, lifestyle, health status, and lipid-lowering medication use) | 1.55 (1.29–1.87) | 1.76 (1.44–2.14) | 1.58 (1.30–1.91) | 1.62 (1.36–1.93) | 1.36 (1.14–1.64) |
| Model 2 + BMI | — | 1.55 (1.19–2.02) | 1.32 (1.04–1.68) | 1.43 (1.17–1.75) | 1.21 (1.00–1.46) |
| Model 2 + VAT | — | — | 1.23 (0.94–1.61) | 1.37 (1.12–1.68) | 1.22 (1.01–1.46) |
| Complete mutual adjustment** | 1.01 (0.75–1.37) | 1.37 (0.99–1.87) | 1.04 (0.78–1.40) | 1.28 (1.03–1.60) | 1.18 (0.96–1.29) |
Odds ratios per 1 SD (95% CI) increase or *decrease in adiposity measure.
**
Adjusted for age, lifestyle, health status, lipid-lowering medication use, BMI, VAT, PAT, liver attenuation, and skeletal muscle attenuation.
Bold indicates P < 0.05.
CI, confidence interval.